Raf Van Campenhout

409 total citations
22 papers, 286 citations indexed

About

Raf Van Campenhout is a scholar working on Molecular Biology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Raf Van Campenhout has authored 22 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 4 papers in Epidemiology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Raf Van Campenhout's work include Connexins and lens biology (15 papers), Heme Oxygenase-1 and Carbon Monoxide (7 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Raf Van Campenhout is often cited by papers focused on Connexins and lens biology (15 papers), Heme Oxygenase-1 and Carbon Monoxide (7 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Raf Van Campenhout collaborates with scholars based in Belgium, Brazil and Switzerland. Raf Van Campenhout's co-authors include Mathieu Vinken, Serge Muyldermans, Nick Devoogdt, Bruno Cogliati, Timo W.M. De Groof, Eva Gijbels, Pieter Annaert, Brenda R. Kwak, Steven Ballet and Vânia Vilas‐Boas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and International Journal of Molecular Sciences.

In The Last Decade

Raf Van Campenhout

21 papers receiving 285 citations

Peers

Raf Van Campenhout

EPIDE

PHARM

HEPAT

SURGE

Owais Ahmad China

Na He China

Xiaoxiao Yao China

Jianming Zhou China

Charlotte Joly France

Christopher W. Dicus United States

Na Yang China

Hong‐Can Ren China

Ling Zuo China

Flavia Lambertucci France

Owais Ahmad China

Raf Van Campenhout

122 ×0.7

78 ×1.9

EPIDE

27 ×0.9

PHARM

17 ×0.6

HEPAT

20 ×0.8

SURGE

Citations per year, relative to Raf Van Campenhout Raf Van Campenhout (= 1×) peers Owais Ahmad

Countries citing papers authored by Raf Van Campenhout

Since Specialization

Citations

This map shows the geographic impact of Raf Van Campenhout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raf Van Campenhout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raf Van Campenhout more than expected).

Fields of papers citing papers by Raf Van Campenhout

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raf Van Campenhout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raf Van Campenhout. The network helps show where Raf Van Campenhout may publish in the future.

Co-authorship network of co-authors of Raf Van Campenhout

This figure shows the co-authorship network connecting the top 25 collaborators of Raf Van Campenhout. A scholar is included among the top collaborators of Raf Van Campenhout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raf Van Campenhout. Raf Van Campenhout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Molica, Filippo, Raf Van Campenhout, Timo W.M. De Groof, et al.. (2025). Nanobody-based Pannexin1 channel inhibitors increase survival after cardiac ischemia/reperfusion. Cell and Tissue Research. 402(1). 121–137.

Campenhout, Raf Van & Mathieu Vinken. (2024). Hepatic cell junctions: Pulling a double‐duty. Liver International. 44(11). 2873–2889. 1 indexed citations

Campenhout, Raf Van, Timo W.M. De Groof, Prashant Kadam, et al.. (2023). Nanobody-based pannexin1 channel inhibitors reduce inflammation in acute liver injury. Journal of Nanobiotechnology. 21(1). 371–371. 5 indexed citations

Campenhout, Raf Van, et al.. (2023). Pannexin1 channels in the liver: an open enemy. Frontiers in Cell and Developmental Biology. 11. 1220405–1220405. 2 indexed citations

Campenhout, Raf Van, et al.. (2022). Connexin‐Based Channels in the Liver. Comprehensive physiology. 12(4). 4147–4163. 2 indexed citations

Caufriez, Anne, Raf Van Campenhout, Julen Sanz-Serrano, et al.. (2022). Effects of Drugs Formerly Suggested for COVID-19 Repurposing on Pannexin1 Channels. International Journal of Molecular Sciences. 23(10). 5664–5664. 3 indexed citations

Campenhout, Raf Van, Bruno Cogliati, & Mathieu Vinken. (2022). Effects of acute and chronic disease on cell junctions in mouse liver. SHILAP Revista de lepidopterología. 22. 1–11. 2 indexed citations

Caufriez, Anne, Raf Van Campenhout, Prashant Kadam, et al.. (2022). Effects of Drugs Formerly Proposed for COVID-19 Treatment on Connexin43 Hemichannels. International Journal of Molecular Sciences. 23(9). 5018–5018. 2 indexed citations

Rodrigues, Bruna dos Santos, et al.. (2021). In Vitro Liver Toxicity Testing of Chemicals: A Pragmatic Approach. International Journal of Molecular Sciences. 22(9). 5038–5038. 29 indexed citations

10.

Campenhout, Raf Van, et al.. (2021). Connexin-Based Channel Activity Is Not Specifically Altered by Hepatocarcinogenic Chemicals. International Journal of Molecular Sciences. 22(21). 11724–11724. 3 indexed citations

11.

Rodrigues, Bruna dos Santos, et al.. (2021). Expression and Functionality of Connexin-Based Channels in Human Liver Cancer Cell Lines. International Journal of Molecular Sciences. 22(22). 12187–12187. 11 indexed citations

12.

Campenhout, Raf Van, et al.. (2021). Mechanisms Underlying Connexin Hemichannel Activation in Disease. International Journal of Molecular Sciences. 22(7). 3503–3503. 43 indexed citations

13.

Campenhout, Raf Van, Serge Muyldermans, Mathieu Vinken, Nick Devoogdt, & Timo W.M. De Groof. (2021). Therapeutic Nanobodies Targeting Cell Plasma Membrane Transport Proteins: A High-Risk/High-Gain Endeavor. Biomolecules. 11(1). 63–63. 14 indexed citations

14.

Campenhout, Raf Van, et al.. (2020). Targeting gap junctional intercellular communication by hepatocarcinogenic compounds. Journal of Toxicology and Environmental Health Part B. 23(6). 255–275. 4 indexed citations

15.

Campenhout, Raf Van, Sara Crespo Yanguas, Eva Gijbels, et al.. (2020). Cholestasis Differentially Affects Liver Connexins. International Journal of Molecular Sciences. 21(18). 6534–6534. 10 indexed citations

16.

Campenhout, Raf Van, Pieter Annaert, Serge Muyldermans, et al.. (2020). Non-canonical roles of connexins. Progress in Biophysics and Molecular Biology. 153. 35–41. 20 indexed citations

17.

Morel, Sandrine, et al.. (2020). Canonical and Non-Canonical Roles of Connexin43 in Cardioprotection. Biomolecules. 10(9). 1225–1225. 32 indexed citations

18.

Vilas‐Boas, Vânia, et al.. (2019). Industrial, Biocide, and Cosmetic Chemical Inducers of Cholestasis. Chemical Research in Toxicology. 32(7). 1327–1334. 21 indexed citations

19.

Deconinck, Eric, Raf Van Campenhout, Michaël Canfyn, et al.. (2018). Combining attenuated total reflectance- infrared spectroscopy and chemometrics for the identification and the dosage estimation of MDMA tablets. Talanta. 195. 142–151. 28 indexed citations

20.

Vilas‐Boas, Vânia, Eva Gijbels, Raf Van Campenhout, et al.. (2018). Primary hepatocytes and their cultures for the testing of drug-induced liver injury. Advances in pharmacology. 85. 1–30. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact